Author

S. D. Gray-Owen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Ranger· 1 shared B. Gordon· 1 shared C. F. Harrigan· 1 shared C. X. Guo· 1 shared D. J. Philpott· 1 shared D. K. Tsang· 1 shared H. Rost· 1 shared H. Y. Gaisano· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Ranger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Bacterial ADP-heptose initiates a revival stem cell program in the intestinal epithelium

S. Goyal, C. X. Guo, A. Ranger, D. K. Tsang, O. Singh, C. F. Harrigan, O. Zaslaver, H. Rost, H. Y. Gaisano, S. Yuzwa, N. Gao, J. L. Wrana, D. J. Philpott, S. D. Gray-Owen, S. Girardin

This study shows that bacterial ADP-heptose triggers a revival stem cell program in the intestinal epithelium by inducing Paneth cell dedifferentiation and ISC loss.

bioRxiv · Jan 15, 2024 · PreprintCell Biology

Paridiprubart inhibits TLR4-dependant NF-κB activation by multiple pathogens

R. Malty, R. Hilbe, S. Ahn, L. Kesselman, J. Lam, K. Kasawara, L. Costa, N. Rajakulendran, B. Gordon, M. Brooks, S. Mubareka, I. Tancevski, S. D. Gray-Owen

This study shows that paridiprubart, a TLR4 inhibitor, suppresses NF-κB activation by multiple pathogens including SARS-CoV-2 and bacterial agents.

bioRxiv · Jun 27, 2023 · PreprintImmunology